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Foot line: Scintigraphy in Acute GIT Bleeding
INTRODUCTION
Gastrointestinal haemorrhage presents in a range from benign, self limiting bleeding through to catastrophic, life threatening blood loss (1) . Bleeding can originate at any point along the gastrointestinal tract (GIT) and 20% to 25% of patients admitted with gastrointestinal haemorrhage have a lower GIT origin (2) . The risk of acute lower gastrointestinal haemorrhage (LGIH) increases with age (3) . Ongoing population aging (absolute and relative increase in age) in developed countries is likely to be paralleled with a higher incidence of LGIH in the future.
Due to the intermittent nature of acute LGIH the detection and localisation of bleeding sites is often difficult which may lead to a delay in treatment of this potentially life threatening condition (4) . Successful management of patients with acute LGIH is reliant on the early diagnosis and accurate localisation of the bleed site (2) . While 85% of LGIH patients stop bleeding spontaneously and, indeed, cessation of active bleeding may have occurred prior to the patient presenting for clinical evaluation, it is prognostically important to identify the remaining 15% of patients who are at a higher risk and in whom there are likely to be benefits of timely intervention management (2) . Therapeutic strategies for acute LGIH are based on both the bleed location (or suspected location) and the rate of bleeding. There are three main interventional approaches; colonoscopy, angiography and surgery.
A variety of diagnostic modalities are now clinically available to assist clinicians in detecting and the localization of the source of LGIH. In the clinical realm there are currently three main options for detection and localisation of LGIH sites; colonoscopy, angiography and technetium-99m ( 99m Tc) red blood cell (RBC) scintigraphy. Among the earliest diagnostic tools is 99m Tc RBC scintigraphy (5) .
Despite the well documented strengths of 99m Tc RBC scintigraphy in acute LGIH, only 10-15% of patients presenting with LGIH are investigated with Nuclear Medicine scintigraphy (3) . This apparent under-utilization may reflect selective avoidance by clinicians due to either a relative lack of familiarity with or confidence in the application of 99m Tc RBC scintigraphy in the assessment of acute LGIH.
Clinicians frequently need to choose between competing diagnostic modalities in the course of their clinical practice. By providing an up-to-date appraisal of the role, strengths and limitations of scintigraphy consistent with the current and future capabilities of nuclear medicine science, this review aims to provide clinicians with a blueprint for the appropriate use of nuclear medicine scintigraphy in the management of LGIH. The blueprint provides a tool to improve clinician familiarity with the role and capability of scintigraphy, to provide clinicians with the confidence to request specific procedural requirements, and to instil clinicians with confidence in the scintigraphic findings to guide patient management.
SCINTIGRAPHIC EVALUATION OF ACUTE LGIH
The first documented use of scintigraphy in the evaluation of gastrointestinal haemorrhage was in 1977 using 99m Tc sulphur colloid (5) . The use of 99m Tc RBC scintigraphy followed in 1979 (5). While each radiopharmaceutical has recognised advantages, 99m Tc tagged RBC is generally the agent of choice for acute LGIH in current nuclear medicine practice (2, 5) . The procedural requirements are summarised in table 1.
Test efficacy:
The efficacy of 99m Tc RBC scintigraphy has been extensively evaluated (2, 4, (6) (7) (8) .
Scintigraphy does, however, rely on the assumption that the patient is actively bleeding during the imaging procedure. Consequently, the standard measures of efficacy may be inappropriately applied to 99m Tc RBC imaging in the acute bleeder if a false negative is simply defined as a negative 99m Tc RBC scan in a patient who presented with symptoms of LGIH. Sensitivity for detecting active bleedings has been reported in the range 78.6% to 97% (2, (7) (8) (9) (10) . Conversely, specificity provides a useful indicator of the value of 99m Tc RBC imaging in the acute bleeder. Specificity has been reported in the range 70.4% to 100% (2,7-10) with the lower ranges reflecting potential sources of false positive findings resulting from the high background radionuclide activity. Importantly, using surgical evidence as the gold standard, 99m Tc RBC imaging has been shown to accurately localise the bleed site in 88% to 97% of patients (11, 12, 13) . It has also been reported that a positive scintigram is associated with a five fold increase in likelihood that the patient would require surgery (13) .
Surgical pathology was also used by Guitierrez et al. (14) to demonstrate an 88% accuracy of localisation in acute LGIH with 99m Tc RBC scintigraphy. Based on their study findings, the investigators (13, 14) concluded that nuclear medicine RBC scintigraphy should be the primary investigation in acute LGIH.
THE STRENGTHS OF 99m
Tc RBC SCINTIGRAPHY Superiority over angiography and colonoscopy: 99m Tc RBC scintigraphy has been shown to be an effective diagnostic and prognostic tool in the evaluation of LGIH, and in many circumstances provides superiority over angiography and colonoscopy in localising bleed sites. In animal and experimental models, 99m Tc RBC scintigraphy has been shown to detect LGIH at bleeding rates as low as 0.04 to 0.1 ml.min -1 (4, (15) (16) (17) which is appreciably superior to the 1.0 ml.min -1 minimum bleeding rate of angiography (4, 16) . 99m Tc RBC scintigraphy has also been shown to have greater sensitivity than angiography for detection of slow bleeding rates or chronic bleeding (15) . Tc RBC imaging allows repeat imaging out to 24 hours which is useful for localising intermittent bleeding (5, 15) . Angiography, in contrast, is limited, particularly in intermittent bleeding, by a narrow window of opportunity for detection corresponding to several minutes (3-4 minutes) following the contrast administration (16, 17) .
Prognostic Impact:
Importantly, the use of 99m Tc RBC scintigraphy has been shown to provide relevant information that is of prognostic significance in the identification of those patients at high risk of recurrent bleeding and in whom more aggressive management is warranted (2, 17) . Furthermore, the relatively simple nature of 99m Tc RBC scintigraphy minimises the potential delays between presentation and diagnosis, which may be experienced with colonoscopy or angiography due to the more complex nature of the latter two procedures. The time to diagnosis has been reported to be an important determinant of outcome in high risk LGIH (15) .
Safety profile:
99m Tc RBC scintigraphy is cheap, low risk, non invasive, accurate, readily available and easily performed in acute illness with no associated morbidity (2, 6, 15) . It should also be noted that the radiation burden to the patient is significantly lower using scintigraphy than angiography (5, 18) . A precise comparison of radiation doses, however, is difficult because separation of the diagnostic and therapeutic components of an angiogram is not practical, the actual angiographic dose vary between operators and the dose determinants differ substantially between individual circumstances.
Colonoscopy is often unsuccessful during active bleeding since, with the exception of slow bleeding rates, the blood can obscure the colonic lumen (15, 17) . Retrograde movement of blood in the colonic lumen can also mimic a more proximal bleeding origin. Colonoscopy during active bleeding is associated with higher risk, is more difficult and, thus, requires a more skilled operator (19) . The colonic preparation required for colonoscopy can result in fluid overload or excess purging may cause dehydration and electrolyte imbalance (15, 20) . Peter and Dougherty (19) indicated that colonic preparation means a delay of four to six hours after admission prior to commencement of colonoscopy. The overall complication rate for colonoscopy is 1.3% and includes serious events such as perforation, haemorrhage, respiratory depression from over sedation in patients with lung disease, bacteraemia, vasovagal reactions, dehydration, volvulus, myocardial ischemic episodes, splenic laceration and explosion of combustible gases (15, 21) .
The disadvantages of angiography in acute LGIH are the availability of skilled staff on short notice, the risk associated with contrast administration and complications associated with the invasive nature of the procedure (15, 22 (20) .
Cost comparisons:
The relative costs of scintigraphy versus angiography in the acute LGIH patient is approximately 1:3 in favour of cheaper scintigraphy (27) . Importantly substantial greater cost saving comes in the ability of scintigraphy, when performed optimally, to reduce unnecessary angiograms, reduce empiric or 'blind' laparotomy and bowel resection, decrease mortality and morbidity and reduce the total health expenditure on patient management (27) .
LIMITATIONS OF SCINTIGRAPHY False positive studies:
A negative 99m Tc RBC scan may be seen as a failure despite the patient not actually bleeding during the procedure. Thus, a true negative might be viewed as a false negative; undermining perceived reliability and subsequent inclination to rely on scintigraphy. The variability in the specificity of 
Reliance on temporal coupling with the time of bleeding:
Traditionally, 99m Tc RBC scintigraphy was performed in an emergent fashion. While the current clinical practice of stabilising the patient prior to pursuing diagnostic evaluation is meritorious, the inherent delay often sees patients presenting well after cessation of bleeding and contributes to the number of negative scans. Indeed, anecdotal evidence suggests that many patients present for 'elective' 
REFINING SCINTIGRAPHY FOR ACUTE LGIH
With the exception of computer acquisition and new invitro RBC kits, acute LGIH scintigraphy has remained largely unchanged since it was first developed in 1977. The absence of technical and procedural advances consistent with more general advances in nuclear medicine and, indeed, competing imaging modalities, undermines clinical utility.
Improving the techniques employed for scintigraphic evaluation of acute LGIH is important to both improved patient management and enhanced resource management which could combine to make patient management more efficient and contribute to decreasing health care costs. There is a need for both technical developments and rigorous adherence to recommended protocol. A number of techniques aimed at improving scintigraphic evaluation of the acute bleeder will be discussed below.
Continuous Dynamic Sampling
Early imaging protocols used discrete (static) images at intervals as wide as five to 15 minutes (2). This sampling frequency may result in false negative studies or inaccurate localisation due to rapid movement of extravasated blood away from the bleed site in either antegrade or retrograde directions (2, 15) . Computer technology has facilitated continuous imaging of the abdomen which has provided more accurate localisation of bleeding sites compared to static acquisitions (2, 15) . O'Neill et al. (15) believe that the success of 99m Tc RBC scintigraphy in acute LGIH hinges on strict adherence to continuous dynamic imaging techniques with a minimum sampling interval of one frame per minute. The dynamic data can be displayed in a continuous real time loop (cinematic display) to more accurately define the nature, origin and behaviour of an accumulation of activity; improving both sensitivity and specificity (15) . Accurate localisation of the bleeding site relies on detection of the site of earliest accumulation of blood rather than simply the most proximal and the cinematic display of rapid dynamic data allows identification of retrograde and antegrade movement away from the actual bleed origin that may not be obvious with standard image assessment.
Delayed Imaging
In negative studies after 60 to 90 minutes of continuous dynamic imaging, delayed imaging at 6 to 24 hours post initial administration of 
Intervention
Glucagon can be used in conjunction with 99m Tc RBC scintigraphy to improve detection and localisation of the bleeding site (29, 30) . It is a polypeptide produced by the pancreas and released to raise blood glucose levels (31) . Glucagon has a similar action to the beta adrenoreceptor mediated actions of adrenaline and, thus, decreases contraction in the gut (decreases peristalsis) which causes stasis of colon transit (31).
Glucagon may also cause an increase in blood pressure, increased cardiac contraction and vasodilation which combine to encourage bleeding. Interestingly, glucagon has the potential to potentiate the effects of oral anticoagulants, increasing the tendency to bleed. The standard dose of 0.25-2.0 mg is administered intravenously (30) . Glucagon has rapid onset with inhibition of motility with one minute of IV administration and a peak inhibition at just 2-4 minutes post IV (30) . The duration, however, is brief at just 9-17 minutes (30) . Consequently, the administration of glucagon should be considered either immediately preceeding the administration of 
Hybrid Systems
Scintigraphy provides sensitive physiological mapping yet suffers from a comparatively poor spatial resolution (anatomical definition) when compared to other diagnostic imaging modalities (eg. CT and MRI). The use of radionuclide enema (32) and tap water enema (33) represent less than successful approaches to provide an outline of the colonic anatomy and to improve bleed localisation. A promising approach that warrants further investigation might be to use image fusion software to co-register the scintigraphic data set with the high anatomic detail provided by computed tomography (CT).
SPECT/CT hybrid scanner technology affords the luxury of both 
Subtraction Scintigraphy
The use of subtraction scintigraphy in 99m Tc RBC evaluation of LGIH has been reported to improve contrast by a number of authors (6, 29) . Subtraction scintigraphy has also been employed to overcome interpretation difficulties associated with the higher background activity in • invitro RBC labelling commenced as soon as possible (as opposed to as soon as practical),
• a rapid dynamic phase (three second sampling) for the first minute after dose administration,
• one minute continuous dynamic sampling for a minimum of 60 minutes (up to 90 minutes) or until convincingly positive,
• perform sequential subtraction imaging on all data sets,
• interpretation should include examination of both one and summed five minute images, subtraction images and cinematic displays,
• delayed imaging, if used, should employ dynamic sampling and a second 'top up' RBC label,
• SPECT/CT data should be interpreted with caution due to potential migration of blood away from the actual bleed site during or prior to the SPECT acquisition, and
• consider planar fusion of the crucial dynamic images (capturing initial bleed)
with CT scout image if using SPECT/CT.
Further clinical evaluation of the role of SPECT/CT, particularly using high resolution CT, should be undertaken to define the role of SPECT/CT in acute
LGIH. An evaluation is also required to explore the role of glucagon in improving SPECT localisation by reducing intra-luminal migration of blood during the SPECT acquisition period. The emerging capability of SPECT/CT systems warrants investigation of a potential role for integrated scintigraphy and CT contrast angiography; combining the benefits of scintigraphy and angiography in a single examination.
CONCLUSION 99m
Tc RBC scintigraphy is a practical and safe diagnostic and prognostic tool in the evaluation of acute LGIH. It has an evidence based clinical role in both detection and precise localisation of bleeding sites that ultimately improve patient outcomes and reduce health care costs. Delays in performing the procedure, high background radiotracer activity and rapid movement of extravasated blood away from the bleed site present limitations which can be overcome by optimisation of study protocol, incorporation of novel imaging technology and techniques such as subtraction scintigraphy and CT co-registration. Tables   Table 1: A summary of the standard procedural requirements for   99m Tc RBC evaluation of acute LGIH. Table 2 : Summary of strategies for optimisation of RBC scintigraphy in LGIH. The table also provides a guide to alternatives, their risks and methods to mitigate the risk for circumstances where the optimal parameters are not satisfied. 
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